Add to Favorites Newsroom RSS Share
Seattle, WA USA

Our News on Newswise

Night Shift Work Associated with Diminished Ability to Repair DNA Damage


A Fred Hutchinson Cancer Research Center study, led by epidemiologist Dr. Parveen Bhatti, found that night shift work is associated with reduced ability to repair DNA lesions. Over time, DNA damage that is not repaired will cause mutations that can...
26-Jun-2017 6:30 PM EDT Add to Favorites

Fred Hutch Study Suggests NSAIDs Improve Survival for Certain Colorectal Cancer Patients


Among long-term colorectal cancer survivors, use of nonsteroidal anti-inflammatory drugs, or NSAIDs, is associated with about a 25 percent reduction in all-cause mortality, according to new research from Fred Hutchinson Cancer Research Center.
13-Jun-2017 7:05 PM EDT Add to Favorites

SWOG Clinical Trials Added More Than 3M Years of Life for Cancer Patients, Fred Hutch Researcher Reports


For an investment of $125 for each year of life gained since the 1950s, the National Cancer Institute-funded SWOG clinical trials program has added 3.34 million years of life for cancer patients in the United States because of successful therapies...
1-Jun-2017 12:45 PM EDT Add to Favorites

Immune Responses From Early Study of Novel Sarcoma Vaccine

The critical component of an experimental vaccine led to an escalating immune response in patients with sarcoma, an indicator of its potential anti-cancer effects. The findings will be presented by Dr. Seth Pollack, a physician-scientist at Fred...
1-Jun-2017 7:05 PM EDT Add to Favorites

Clinical Trial Shows Experimental Drug’s Ability to Knock Down Pancreatic Cancer’s Defense


By adding an experimental drug to a standard chemotherapy regimen, a subset of patients with metastatic pancreatic cancer had a significantly longer period before the cancer progressed as compared with those who received the standard treatment,...
31-May-2017 2:05 PM EDT Add to Favorites

Triple Immunotherapy for Rare Skin Cancer Shows Promise in Small, Early-Stage Trial


Combo of T-cell therapy, newly FDA-approved drug and another immunotherapeutic agent kept cancer at bay for three out of four patients with metastatic Merkel cell carcinoma. The findings will be presented June 5 at the annual meeting of the American...
30-May-2017 1:05 PM EDT Add to Favorites

Many Cancer Patients’ Emergency Department Visits Appear Preventable, Fred Hutch Study Finds


As many as 53 percent of cancer patients’ Emergency Department visits that do not require admission could be avoided with better symptom management and greater availability of outpatient care tailored to their needs, according to a new study from...
30-May-2017 12:05 PM EDT Add to Favorites

Many Patients with Early-Stage Breast Cancer Receive Costly, Inappropriate Testing, Says Fred Hutch Study


A study from Fred Hutchinson Cancer Research Center that will be presented at the American Society of Clinical Oncology annual meeting on June 5 in Chicago shows that asymptomatic women who have been treated for early-stage breast cancer often...
24-May-2017 9:05 PM EDT Add to Favorites

Our Experts on Newswise

Embargoed Research: In Fred Hutch Study, Obese Women Who Lost Weight Significantly Lowered Levels of Proteins in the Blood That Help Certain Tumors Grow


12-Jul-2016 12:05 AM EDT

Fred Hutch Expert Available to Discuss New Recommendations for Colorectal Cancer Screening


15-Jun-2016 6:05 PM EDT

Fred Hutch Expert Available to Discuss NEJM Article on Biomarker Tests for Molecularly Targeted Therapies


Gary H. Lyman, MD, MPH, an internationally recognized oncologist and health economist at Fred Hutchinson Cancer Research Center and a member of a committee of the National Academies of Sciences, Engineering, and Medicine (NASEM), is available to...
14-Jun-2016 1:05 AM EDT

Expert Available to Discuss New Study About the Future of Personalized Breast Cancer Treatment


If you’re seeking an expert to discuss a new study (in Nature) about the future of personalized breast cancer treatment, Dr. Amanda (Mandy) Paulovich, Oncologist and Geneticist at Fred Hutchinson Cancer Research Center and one of the study’s...
25-May-2016 1:05 PM EDT

Experimental HIV Vaccine Regimen to Be Tested in Large-Scale Clinical Trial; Could Lead to First Licensed AIDS Vaccine.


18-May-2016 7:05 PM EDT

#Exercise and #Cancer Risk: @Fredhutch Expert Can Comment on Study in Today's JAMA Internal Medicine


16-May-2016 12:05 PM EDT

Cancer and Mental Health Disorders: @FredHutch Survivorship Expert Available to Discuss New Findings


28-Apr-2016 12:05 PM EDT

Malaria Expert Available: Volunteers Roll Up Sleeves and Get Infected to Test Experimental Drug in Seattle


25-Apr-2016 4:05 PM EDT

Our YouTube Videos

Chat now!